Clarity Diagnostics CLA-COV19AG-VIS COVID-19 Antigen Test Cassette

Clarity Diagnostics, CLA-COV19AG-VIS, COVID-19 Antigen Rapid Test Cassette

CLA-COV19AG-VIS Includes Only:

• 25 Individually Pouched Test Cassettes
• 25 Sterile Naso-Pharyngeal Swabs
• 25 Buffer Tubes
• 1 Negative Control Swab
• 1 Positive Control Swab
• 1 Work Station
• 1 Package Insert
• 1 Quick Start Guide

Features:

• EUA Approved & CLIA Waived
• POCT Approved
• TAA Compliant
• Relative Sensitivity: 87.5%
• Relative Specificity: >98.9%
• Positive Results as Fast as 5 Minutes
• Naso-Pharyngeal Test Swab
• Made in Finland

In response to the worldwide pandemic, Clarity is proud to introduce a line of reliable COVID-19 products. COVID-19 products are Pathway C EUA-approved and are proudly manufactured in Finland. With a continuing pandemic, the need for accurate results and reliable tests is of the utmost importance, which is why COVID products are made to be quick, easy to use, and above all accurate.

• This test is not approved for OTC use or At-Home use.
• The Clarity COVID-19 Antigen test can be used to test directly collected nasopharyngeal swab specimens.
• The Clarity COVID-19 Antigen test should be ordered for the detection of COVID-19 antigen in individuals who are suspected of COVID-19 by their healthcare provider and who are within six days of symptom onset.
• The Clarity COVID-19 Antigen test is authorized for use in laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet requirements to perform high complexity, moderate complexity, or waived tests. This test is authorized for use at the Point of Care (POC), i.e., patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.